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eqBACKGROUND The European Society of Cardiology (ESC) recommends the 0/1-h algorithm for rapid triage of patients
with suspected non–ST-segment elevation myocardial infarction (MI). However, its impact on patient management and
safety when routinely applied is unknown.
OBJECTIVES This study sought to determine these important real-world outcome data.
METHODS In a prospective international study enrolling patients presenting with acute chest discomfort to the
emergency department (ED), the authors assessed the real-world performance of the ESC 0/1-h algorithm using high-
sensitivity cardiac troponin T embedded in routine clinical care and its associated 30-day rates of major adverse cardiac
events (MACE) (the composite of cardiovascular death and MI).
RESULTS Among 2,296 patients, non–ST-segment elevation MI prevalence was 9.8%. In median, 1-h blood samples
were collected 65 min after the 0-h blood draw. Overall, 94% of patients were managed without protocol violations, and
98% of patients triaged toward rule-out did not require additional cardiac investigations including high-sensitivity
cardiac troponin T measurements at later time points or coronary computed tomography angiography in the ED. Median
ED stay was 2 h and 30 min. The ESC 0/1-h algorithm triaged 62% of patients toward rule-out, and 71% of all patients
underwent outpatient management. Proportion of patients with 30-day MACE were 0.2% (95% confidence interval:
03% to 0.5%) in the rule-out group and 0.1% (95% confidence interval: 0% to 0.2%) in outpatients. Very low MACE
rates were confirmed in multiple subgroups, including early presenters.
CONCLUSIONS These real-world data document the excellent applicability, short time to ED discharge, and
low rate of 30-day MACE associated with the routine clinical use of the ESC 0/1-h algorithm for the management
of patients presenting with acute chest discomfort to the ED. (J Am Coll Cardiol 2019;74:483–94)
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484P atients with symptoms suggestive ofacute myocardial infarction (MI) ac-count for about 10% of all emergency
department (ED) consultations (1). Rapid
identification of MI as a life-threatening dis-
order is important for the early initiation of
appropriate, evidence-based, and effective
therapy (2). In addition, rapid and safe rule-
out of MI is of major medical and economic
importance because it allows the timely
detection and treatment of alternative causes
of acute chest pain (2). Many of the alternative
causes of acute chest pain are benign, so that
rule-out of MI allows patient reassurance and
often consideration of discharge from the ED
and outpatient management (2,3).SEE PAGE 495Electrocardiography (ECG) and serial sampling of
cardiac troponin (cTn) complement clinical assess-
ment and form the diagnostic cornerstones for MI in
the ED (2,3). Supported by evidence from large diag-
nostic studies, the latest guidelines of the European
Society of Cardiology (ESC) for the first time recom-
mended the use of a 0/1-h algorithm to rapidly rule
out or rule in non–ST-segment elevation myocardial
infarction (NSTEMI) based on high-sensitivity cardiac
troponin (hs-cTn) concentrations at presentation
and their absolute 1-h changes (2,4–6). In theseas supported by research grants from the Swiss National Science
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ingly, patients were not actually managed according
to the triage recommendation of the ESC 0/1-h algo-
rithm. Therefore, several important questions related
to the use of the ESC 0/1-h algorithm in routine clin-
ical practice remain unknown (7). These include the
feasibility, for example, the exact time interval
passed between the 0-h and 1-h blood draw, the
adherence, for example, the percentage of patients
managed without protocol violations, the triage-
performance, quantified as the proportion of pa-
tients triaged toward rule-out or rule-in, as well as the
proportion of patients undergoing outpatient man-
agement, the impact on patient flow in the ED as
quantified by the time to ED discharge, and ulti-
mately, the associated 30-day rates of major adverse
cardiac events (MACE) in the rule-out group as well as
in outpatients when embedding the ESC 0/1-h algo-
rithm in clinical routine in a busy ED (3–6).
The aim of this prospective multicenter study was
to document this important information.
METHODS
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485hospitals—the University Hospital Basel, Switzerland
and the Cardiovascular Institute of Buenos Aires,
Argentina—between October 2015 and June 2017 after
written informed consent was obtained. Patients
presenting with ST-segment elevation MI were
excluded. This study was carried out in accordance
with the principles of the Declaration of Helsinki and
approved by the local ethics committees. The authors
designed the studies, and gathered and analyzed the
data according to the STARD guidelines for studies of
diagnostic accuracy (8) (Online Table 1), vouched for
the data and analysis, wrote the paper, and decided to
submit it for publication.
ROUTINE CLINICAL ASSESSMENT AND MANAGEMENT.
Patients underwent clinical assessment that included
medical history, physical examination, standard
blood test including serial measurements of high-
sensitivity cardiac troponin T (hs-cTnT), 12-lead ECG,
continuous ECG rhythm monitoring, and pulse ox-
imetry. In both institutions, the ESC 0/1-h algorithm
was an integral part of the local standard operating
procedures for the management of patients with
suspected NSTEMI (2). The patients’ management
was left to the discretion of the attending physicians,
who were unaware of the documentation of the
outcome measures of this study. Treating physicians
were free to overrule the triage recommendation of
the ESC 0/1-h algorithm whenever deemed necessary.
In fact, when introduced for routine clinical care
(October 1, 2015, in Basel and January 1, 2016, in
Buenos Aires) and during continuing medical educa-
tion ever since, ED physicians were advised to always
put the triage recommendation provided by the ESC
0/1-h algorithm into perspective with full clinical
assessment and the detailed analysis of the ECG (2,3).
hS-cTnT MEASUREMENTS. As required by the ESC
0/1-h algorithm, hs-cTnT was routinely determined at
presentation to the ED and after 1 h. Serial sampling
on the ED was discontinued already after the first
measurement if a patient qualified for direct rule-out
(0-h hs-cTnT <5 ng/l and chest pain onset >3 h before
ED presentation) or direct rule-in of NSTEMI (0-h hs-
cTnT $52 ng/l) according to the ESC 0/1-h algorithm.
Average turnaround time from blood sampling
until availability of the hs-cTnT concentration in the
electronic health record of the patient was approxi-
mately 1 h.
The hs-cTnT assay (Elecsys 2010 high-
sensitivity troponin T; Roche Diagnostics, Rotkreuz,
Switzerland) has a 99th percentile concentration of
14 ng/l with a corresponding CV of 10% at 13 ng/l (9).
Limit of blank and limit of detection have been
determined to be 3 ng/l and 5 ng/l, respectively. Noneof the hs-cTnT measurements in this analysis were
affected by the 2010 to 2012 calibration shift (10).
ESC hs-cTnT 0/1-H ALGORITHM. The ESC 0/1-h al-
gorithm, which should always be used in conjunction
with all clinical information available including the
ECG, triages patients presenting with acute chest
discomfort and/or angina pectoris toward rule-out,
observe, and rule-in on the basis of assay-specific
hs-cTnT cutoff concentrations obtained at presenta-
tion and after 1 h (Online Figure 1A) (2). The assay-
specific cutoff concentration of hs-cTnT were
derived and validated in diagnostic multicenter
studies, in which study measurements were per-
formed blinded to the treating physician and an
adjudicated final diagnosis, done by 2 independent
cardiologists on the basis of serial hs-cTn sampling,
cardiac imaging, and clinical follow-up, served as the
reference standard against which the triage recom-
mendation of the 0/1-h algorithm was compared
(Online Figure 1B) (4,5). According to these simula-
tions of the exclusive use of the ESC 0/1-h algorithm,
patients triaged toward rule-out indicate a very low
likelihood of NSTEMI (<0.5%), whereas patients tri-
aged toward rule-in have a likelihood of NSTEMI of
about 70% to 85% and therefore, in general, are
appropriate candidates for admission to a monitored
unit and early coronary angiography (3–5). Many, but
not all patients, in whom NSTEMI is ruled out are
candidates for early discharge from the ED. Alterna-
tive causes of chest pain with a life-threatening po-
tential (e.g., aortic dissection, pulmonary embolism,
pneumothorax) or a need for in-hospital management
(e.g., severe pneumonia) need to be considered (2,3).
FOLLOW-UP. One month after discharge, patients
were contacted by telephone calls or in written form
to evaluate the possible recurrence of chest pain and
the occurrence of MACE including cardiovascular
death and MI. Follow-up information was further-
more obtained from the patient’s electronic health
care records, the family physician’s records, and the
national registry on mortality.
MAIN OUTCOME MEASURES. Feasibility was assessed
by the observed time interval between the 0-h and 1-h
blood draws, targeting 60 min. Adherence was
assessed as the percentage of patients managed
without protocol violations (e.g., rule-out of NSTEMI
with a single measurement [rather than 2] in early
presenters, defined as patients presenting within the
first 3 h after chest pain onset). In addition, we
assessed the use of ED resources, quantified as the
percentage of patients triaged toward rule-out by the
ESC 0/1-h algorithm who needed additional cardiac
investigations in the ED including hs-cTnT
TABLE 1 Baseline Characteristics According to ESC 0/1-h Algorithm Triage Groups and Management Decision
Overall
(N ¼ 2,296)










(n ¼ 677) p Value
Age, yrs 60 (49–71) 55 (44–65) 71 (60–78) 68 (59–80) <0.001 57 (46–68) 68 (57–77) <0.001
Female 819 (36) 587 (41) 153 (26) 79 (27) <0.001 616 (38) 203 (30) <0.001
Time since CPO, h 6 (2–15) 5 (2–13) 6 (3–23) 5 (2–12) <0.001 5 (2–12) 6 (3–24) <0.001
Early presenters, #3 h after CPO 819 (36) 546 (38) 162 (28) 111 (38) <0.001 613 (38) 206 (30) 0.001
Cardiovascular risk factors
Hypertension 1161 (51) 555 (39) 415 (71) 191 (65) <0.001 710 (44) 451 (67) <0.001
Hypercholesterolemia 947 (41) 483 (34) 316 (54) 148 (50) <0.001 578 (36) 369 (55) <0.001
Diabetes mellitus 289 (13) 98 (7) 127 (22) 64 (22) <0.001 147 (9) 142 (21) <0.001
Current smoking 444 (19) 286 (20) 96 (17) 62 (21) 0.131 309 (19) 135 (20) 0.636
Family history of premature CAD 361 (16) 230 (16) 82 (14) 49 (17) 0.460 239 (15) 122 (18) 0.050
History
Known CAD 656 (29) 290 (20) 244 (42) 122 (41) <0.001 375 (23) 281 (42) <0.001
Previous myocardial infarction 382 (17) 160 (11) 147 (25) 75 (25) <0.001 206 (13) 176 (26) <0.001
Previous PCI 519 (23) 240 (17) 190 (33) 89 (30) <0.001 302 (19) 217 (32) <0.001
Previous CABG 157 (7) 47 (3) 71 (12) 39 (13) <0.001 85 (5) 72 (11) <0.001
Peripheral artery disease 74 (3) 20 (1) 34 (6) 20 (7) <0.001 31 (2) 43 (6) <0.001
Previous stroke 52 (2) 16 (1) 19 (3) 17 (6) <0.001 24 (1) 28 (4) <0.001
Chronic kidney disease 129 (6) 17 (1) 68 (12) 44 (15) <0.001 39 (2) 90 (13) <0.001
hs-cTnT
hs-cTnT at presentation, ng/l 8 (4–15) 5 (3–7) 16 (12–23) 73 (27–205) — 6 (3–10) 20 (9–57) —
hs-cTnT after 1 h, ng/l 9 (5–19) 6 (4–8) 17 (13–24) 79 (37–218) — 7 (5–11) 22 (10–63) —
1-h change, ng/l 1 (0–2) 1 (0–1) 1 (1–2) 11 (6–41) — 1 (0–1) 2 (1–9) —
Values are median (interquartile range) or n (%). Continuous variables were compared with the Mann-Whitney U test, and categorical variables using the Pearson chi-square test or Fisher exact test, as
appropriate.
CABG ¼ coronary artery bypass grafting; CAD ¼ coronary artery disease; CPO ¼ chest pain onset; ESC ¼ European Society of Cardiology; PCI ¼ percutaneous coronary intervention; hs-cTnT ¼ high-
sensitivity cardiac troponin T.
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486measurements at later time points (e.g., 3 to 12 h) or
coronary computed tomography (CT) angiography,
and the percentage of patients ruled-in and hospi-
talized in a monitored unit and/or undergoing early
coronary angiography (i.e., within 24 h). The impact
on patient flow in the ED was quantified by the time
to ED discharge/transfer and the percentage of ruled-
out patients managed as outpatients.
The coprimary outcome measures were triage-
performance and associated 30-day MACE rates
of the ESC 0/1-h algorithm and subsequent
outpatient management. Patients were classified as
outpatients if they were directly discharged from
the ED within the first 24 h without prior transfer
to a cardiac catheterization laboratory, intensive
care unit, observation unit, or regular ward. Triage-
performance was quantified by the proportion of
patients triaged toward rule-out or rule-in of NSTEMI
by the ESC 0/1-h algorithm as well as by the propor-
tion of outpatient management. MACE rates in the
rule-out group and in outpatients were quantified by
the proportion of patients with MACE within the first30 days, defined as the composite of cardiovascular
death and MI including the index event. Diagnosis of
MI was adjudicated by an independent cardiologist
not involved in the actual treatment of the respective
patients within each participating institution
including hs-cTnT according to the universal defini-
tion of MI (2,11,12). In brief, MI was diagnosed when
there was evidence of myocardial necrosis in associ-
ation with a clinical setting consistent with myocar-
dial ischemia. Myocardial necrosis was diagnosed by
at least 1 hs-cTnT value above the 99th percentile
together with a significant rise or fall. To help put
the findings of this post-implementation study into
the appropriate clinical context, we added a direct
comparison with a pre-implantation cohort enrolled
in 7 hospitals (University Hospital Basel, University
Hospital Zürich, Kantonsspital Bruderholz, and
Kantonsspital Liestal, all in Switzerland; Zabrze Uni-
versity Hospital, Poland; Brno University Hospital,
Czech Republic; and Hospital del Mar, Barcelona,
Spain), using identical inclusion and exclusion
criteria as well as identical criteria to quantify and
CENTRAL ILLUSTRATION European Society of Cardiology 0/1-h Algorithm: Real-World Performance Summary
2,296 Patients
with Acute Chest Discomfort
Resampling of High-Sensitivity Cardiac Troponin T
after 1 Hour
Median ED Stay of 150 minutes
EXCELLENT OUTPATIENT SAFETY
30-day MACE Rate 0.1%
EXCELLENT RULE-OUT SAFETY
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The ESC 0/1-h algorithm allows a very rapid, efficient, and safe triage of patients with acute chest discomfort. ED ¼ emergency department; MACE ¼ major adverse
cardiac events.
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487compare time to ED discharge, proportion of outpa-
tient management, and 30-day MACE rates including
adjudication of MI (13).
STATISTICAL ANALYSIS. All continuous variables
are expressed as median (interquartile range) and all
categorical variables as numbers and percentages.
Details on the statistical analysis can be found in the
Methods section of the Online Appendix.
RESULTS
PATIENT CHARACTERISTICS. Overall, 2,296 patients
presenting with symptoms suggestive of MI were
eligible for this analysis (Online Figure 2). Median age
was 60 years, 36% were women, 29% had known
coronary artery disease, and 36% were early pre-
senters that presented to the ED within the first 3 hafter chest pain onset (Table 1, Online Table 2).
Prevalence of NSTEMI at the time of index admission
was 9.8% (224 of 2,296).
FEASIBILITY. Median time between the 0-h and 1-h-
blood draw was 65 min (61 to 72 min), as compared
with the targeted 60 min (Online Figure 3).
ADHERENCE AND RESOURCE USE. Overall, 94%
(95% confidence interval [CI]: 93% to 95%) of patients
were managed without protocol violations. The most
frequent protocol violation was ED discharge without
collection of a second (1-h) hs-cTnT measurement in
123 patients presenting within the first 3 h after chest
pain onset (5%). In 4 patients (0.2%) presenting
within the first 3 h after chest pain onset treated
as inpatients, no serial hs-cTnT testing was per-
formed after the initial measurement. Two patients
















Time spent on the ED, min 150 (134–235) 150 (130–215) 156 (143–273) 150 (140–265) 150 (130–205) 180 (140–318)
Overnight stays, nights 0 (0–2) 0 (0–0) 1 (0–5) 5 (3–9) 0 (0–0) 5 (2–8)
Outpatient management 1,619 (70.5) 1,243 (87.5) 352 (60.6) 24 (8.1) 1,619 (100.0) 0 (0.0)
Procedures during 30-day follow-up
Cardiac stress testing 196 (8.5) 125 (8.8) 58 (10.0) 13 (4.4) 104 (6.4) 92 (13.6)
Functional imaging 144 (6.3) 86 (6.1) 46 (7.9) 12 (4.1) 68 (4.2) 76 (11.2)
Ergometry 131 (5.7) 81 (5.7) 39 (6.7) 11 (3.7) 61 (3.8) 70 (10.3)
Coronary angiography 402 (17.5) 82 (5.8) 109 (18.8) 211 (71.5) 14 (0.9) 388 (57.3)
Revascularization 269 (11.7) 62 (4.4) 69 (11.9) 151 (51.2) 10 (0.6) 272 (40.2)
PCI 218 (9.5) 49 (3.5) 53 (9.1) 116 (39.3) 1 (0.1) 217 (32.1)
CABG 54 (2.4) 1 (0.1) 17 (2.9) 36 (12.2) 0 (0.0) 54 (8.0)
No CAD testing 1,730 (75.3) 1,226 (86.3) 426 (73.3) 78 (26.4) 1,503 (92.8) 227 (33.5)
Outcomes during 30-day follow-up
MACE 231 (10.1) 3 (0.2) 31 (5.3) 197 (66.8) 1 (0.1) 230 (34.0)
Myocardial infarction 227 (9.9) 2 (0.1) 30 (5.2) 195 (66.1) 0 (0.0) 227 (33.5)
At index admission 224 (9.8) 0 (0.0) 29 (5.0) 195 (66.1) 0 (0.0) 224 (33.1)
Death 8 (0.3) 2 (0.1) 1 (0.2) 5 (1.7) 1 (0.1) 7 (1.0)
Cardiovascular death 5 (0.2) 1 (0.1) 1 (0.2) 3 (1.0) 1 (0.1) 4 (0.6)
Values are median (interquartile range) or n (%). Continuous variables were compared with the Kruskal-Wallis or Mann-Whitney U test, and categorical variables using the
Pearson chi-square test or Fisher exact test, as appropriate. MACE was defined as the composite of myocardial infarction (including index event) and cardiovascular death within
30 days after index presentation to the emergency department. Functional imaging was defined as stress echocardiography or myocardial perfusion scintigraphy.
ED ¼ emergency department; MACE ¼ major adverse cardiac event; other abbreviations as in Table 1.
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488(0.1%: 1 patient with NSTEMI in the rule-in group,
1 patient with unstable angina in the rule-out group)
were admitted to the hospital, but left the hospital
against medical advice on the day of admission. In
3 patients (0.1%), first hs-cTnT retesting was per-
formed after 3 h instead of 1.
Among all patients triaged toward rule-out by the
ESC 0/1-h algorithm, 2% (95% CI: 2% to 3%) required
additional cardiac investigations on the ED including
hs-cTnT measurements at later time points (e.g., 3 to
12 h) or coronary CT angiography. Subsequent cardiac
stress testing within 30 days was performed in 9% of
patients in the rule-out group and in 6% of out-
patients, which was not performed during ED stay.
Among patients triaged toward rule-in, 46% (95% CI:
41% to 52%) were hospitalized in a monitored unit
and 67% (95% CI: 61% to 72%) underwent early cor-
onary angiography.
IMPACT ON PATIENT FLOW IN THE ED AND
TRIAGE-PERFORMANCE. Main findings are summa-
rized in the Central Illustration. Median time to
discharge or transfer from the ED was 2 h 30 min (2 h
14 min to 3 h 55 min) in the overall population
(Table 2, Figure 1).
The ESC 0/1-h algorithm triaged 62% (95% CI: 60%
to 64%) of patients toward rule-out and 13% (95% CI:12% to 14%) toward rule-in, leaving only 25% (95% CI:
23% to 27%) in the observe zone (Figure 2). Twenty-
two percent (95% CI: 21% to 24%) of patients were
eligible for direct rule-out and 8% (95% CI: 7% to 9%)
for direct rule-in of NSTEMI on the basis of the 0-h hs-
cTnT concentration only without the need for serial
hs-cTnT testing at 1 h.
Ultimately, 71% (95% CI: 69% to 72%) of patients
were managed as outpatients. Among patients triaged
toward rule-out of NSTEMI, 88% (95% CI: 86% to
89%) were discharged directly from the ED for
outpatient management. In those, 92% (95% CI: 91%
to 94%) did not undergo any further outpatient
testing for coronary artery disease. Baseline charac-
teristics and patient management according to
disposition in each triage group are fully listed in
Online Tables 3 and 4.
ASSOCIATED 30-DAY MACE RATES. Data on 30-day
follow-up were available in all patients (100%).
Within 30 days, MACE rate was 0.2% (95% CI: 0.0% to
0.5%) in the rule-out group and 0.1% (95% CI: 0.0% to
0.2%) in outpatients. No patient with MI at index
admission was incorrectly triaged toward rule-out for
NSTEMI (missed MI rate 0%) or treated as outpatient
(inappropriate discharge rate 0%). Subsequent MI
within 30 days occurred in 2 patients (0.1%; 95% CI:

















































































Time to ED Discharge (Hours)
13121110 23222120191817161514 24
Management Decision Outpatient Inpatient
(A) Time to discharge in the overall population; (B) according to the triage by the ESC 0/1-h algorithm; (C) according to the management
decision. ED ¼ emergency department; ESC ¼ European Society of Cardiology.
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n = 581 (25%)
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Flow-chart depicting the real-world performance of the ESC 0/1-h algorithm for rapid triage of suspected myocardial infarction (MI). Triage recommendations (rule-out
vs. observe vs. rule-in of MI) are depicted in the upper panel, whereas final management decisions (outpatient vs. inpatient) are depicted in the lower panel. *If chest
pain onset >3 h before presentation to the emergency department. 1-h change ¼ absolute (unsigned) change of high-sensitivity cardiac troponin T (hs-cTnT) within 1 h;
cvDeath30d ¼ cardiovascular death at 30 days; ESC ¼ European Society of Cardiology; MACE30d ¼ major adverse cardiac events at 30 days; MI30d ¼ myocardial
infarction at 30 days including the index event; MIIndex ¼ myocardial infarction at index presentation; NSTEMI ¼ non–ST-segment elevation myocardial infarction.
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4900% to 0.4%) triaged to the rule-out group (days 5 and
8), that were both treated as inpatients. No MI within
30 days occurred in outpatients. One female patient
triaged to the rule-out group and treated as outpa-
tient was found dead on day 29 without any evidence
supporting a specific noncardiovascular cause of
death and therefore accounted for the 1 adjudicated
cardiovascular death observed in the rule-out and
outpatient group. Details of the 3 patients with a30-day MACE that were missed by the ESC 0/1-h al-
gorithm are listed in Online Table 5.
COMPARISON WITH PRE-IMPLEMENTATION COHORT.
Baseline characteristics of patients with suspected
NSTEMI enrolled in the pre-implementation cohort
(Online Table 6) were comparable to that in the post-
implementation cohort, for example, median age 59
years versus 60 years. Median time to ED discharge
was 4 h 45 min (3 h 19 min to 6 h 30 min), which was




















































































































0.0 0.80.60.40.2 1.0 0.20.0 0.80.60.4 1.0
The first column indicates triage-performance of the ESC 0/1-h algorithm, quantified by the proportion of patients either ruled-out or ruled-in
for non–ST-segment elevation myocardial infarction. The second column indicates proportion of outpatient management. The third and
fourth columns indicate 30-day MACE rates in patients assigned to rule-out and rule-in outpatients, respectively. CAD ¼ coronary artery
disease; CKD¼ chronic kidney disease; CPO ¼ chest pain onset; ESC¼ European Society of Cardiology; MACE ¼major adverse cardiac events;
site A ¼ University Hospital of Basel, Switzerland; site B ¼ Instituto Cardiovascular de Buenos Aires, Argentina.
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491significantly longer as compared with that in the post-
implementation cohort (p < 0.001) (Online Table 7).
Overall, 61% of patients in the pre-implementation
cohort were managed as outpatients, which was a
significantly lower proportion than in the post-
implementation cohort (p < 0.001). Within 30 days,
MACE rate was 1.7% (95% CI: 1.0% to 2.4%) in out-
patients in the pre-implementation cohort, which was
significantly higher as compared with the rate in the
post-implementation cohort (p < 0.001).
PERFORMANCE OF THE ESC 0/1-H ALGORITHM IN
PRE-DEFINED SUBGROUPS. Pre-defined subgroup
analyses of the ESC 0/1-h algorithm’s performance
according to time since chest pain onset, sex, age,
presence of known coronary artery disease or chronic
kidney disease, as well as recruitment site, revealed
highly robust findings documenting very low 30-day
MACE rates in the rule-out group and in outpatients
in all subgroups (no significant interaction p values)
(Figure 3). By contrast, triage-performance differed
between most of the observed subgroups. For
example, in the vulnerable subgroup of early pre-
senters, presenting to the ED within the first 3 h after
chest pain onset, 30-day MACE rate in the rule-out
group and in outpatients were 0.0% (0 of 546 and0 of 613, respectively), as compared with 0.3% (3 of
874) and 0.1% (1 of 1,006) in late presenters (p ¼ 0.171
and 0.435, respectively). In early presenters, 80%
(95% CI: 78% to 83%) of patients were either triaged
toward rule-out or rule-in and 75% (95% CI: 72% to
78%) underwent outpatient management as
compared with 72% (95% CI: 69% to 74%) and 68%
(95% CI: 66% to 71%) in late presenters, respectively
(p <0.001 and 0.001).
Data on predictors for hospital admission, cardiac
stress testing and revascularization among patients
ruled out for NSTEMI, as well as on predictors of
outpatient management in patients triaged toward
the observe or rule-in group by the ESC 0/1-h algo-
rithm can be found in the result section of the Online
Appendix, Online Tables 8 to 12.
DISCUSSION
To the best of our knowledge, this is the first inter-
national multicenter study that investigates in detail
the real-world performance of the ESC 0/1-h algo-
rithm using hs-cTnT applied in routine clinical care in
unselected patients presenting with acute chest
discomfort suggestive of NSTEMI to the ED. We report
7 major novel findings:
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gorithm seems to be highly feasible also in busy EDs,
as the median time to the 1-h blood sample was
65 min. Second, adherence to the ESC 0/1-h algorithm
was high with 94% of all patients assessed without
protocol violations. The most frequent protocol
violation was ED discharge without collection of a 1-h
hs-cTnT measurement in patients presenting within
the first 3 h after chest pain onset. It is important to
highlight that direct rule-out by the ESC 0/1-h algo-
rithm is not permitted in such early presenters,
because very low but still rising hs-cTnT concentra-
tions could be potentially missed. Use of the ESC
0/1-h algorithm within a clinical decision support
system embedded in the electronic patient document
has the potential to further reduce the likelihood of
protocol violations. Third, only 2% of all patients in
the rule-out group did require additional cardiac in-
vestigations including hs-cTnT measurements at later
time points or CT angiography in the ED. Fourth,
median ED length of stay was 2.5 h, which is sub-
stantially shorter as in the pre-implementation cohort
and reported when using alternative ED protocols for
patients with suspected NSTEMI both in the United
States (14,15) or Europe (13,16). A recent European
multicenter study assessed the real-world impact of
the introduction of hs-cTnT within the ESC 0/3-h al-
gorithm on clinical management and reported a me-
dian ED stay duration of about 6.5 h when using a
conventional, nonsensitive cTnT assay and 5 h after
the introduction of hs-cTnT, applied according to the
ESC 0/3-h algorithm (13). Similarly, median ED stay
duration was 6.3 h in low-risk patients in a recent
Dutch study (16), 8.6 h in a U.S. study routinely using
coronary CT angiography, and even >24 h in their
control group (14). Therefore, the use of the ESC 0/1-h
algorithm seems to further accelerate the clinical
management of patients with suspected NSTEMI and
thereby may help reducing ED crowding, which is
known to be associated with adverse outcomes (17).
The reduction in treatment costs associated with the
profound reduction in length of stay in the ED is
likely also substantial, particularly as the need for
additional cardiac investigations in patients triaged
toward rule-out was very low. Fifth, triage-
performance of the ESC 0/1-h algorithm was high
and allowed rapid rule-out or rule-in of NSTEMI in 3
patients of 4 within 1 h of resampling. Ultimately, 71%
of patients were managed as outpatients, which is a
higher proportion as in the pre-implementation
cohort and reported when using alternative ED pro-
tocols for patients with suspected NSTEMI both in the
United States (14,15) or Europe (13,16). These real-
world findings are highly comparable to data fromprevious diagnostic studies that estimated the effi-
cacy of the 0/1-h algorithm using hs-cTnT (4,5). Sixth,
and likely of utmost importance, the observed 30-day
MACE rates were very low in the rule-out group and
in outpatients, and lower as compared with that
observed in the pre-implementation cohort and re-
ported when using alternative ED protocols for pa-
tients with suspected NSTEMI both in the United
States (14,15) or Europe (13,16). Seventh, subgroup
analyses according to time since chest pain onset,
sex, age, known coronary artery disease, presence of
chronic kidney disease as well as recruitment site
confirmed very low MACE rates and high triage-
performance of the ESC 0/1-h algorithm in all pre-
defined subgroups.
These findings extend and corroborate previous
work related to the clinical evaluation of hs-cTn as-
says in the early diagnosis of MI that allowed the
development of several novel hs-cTn–based strate-
gies accelerating the triage of patients with suspected
NSTEMI (4–6,18–25). In 2011, the ESC introduced a
0/3-h algorithm for accelerated patients’ triage, which
is still the standard of care in many institutions
worldwide and allows the rule-out of NSTEMI in
about 40% to 45% of patients with appropriate safety
(2,26). Besides, a 0/2-h algorithm combining serial hs-
cTnI testing with a clinical risk score, the Thrombol-
ysis In Myocardial Infarction (TIMI) score, has been
developed, allowing rule-out of NSTEMI in 42% of
patients with a 30-day MACE rate of 0.8% (19).
Alternatively, a recent large meta-analysis
comprising 22,457 patients investigated a single hs-
cTnI cutoff approach and reported high efficacy
(49% of patients ruled out) and high safety with a 30-
day MACE rate of 0.5% among ruled-out patients (25).
In addition, a recent U.S. study investigated the effi-
cacy and safety of the routine application of the
HEART (history, electrocardiogram, age, risk factors
and troponin) score and serial cTnI testing at 0 h and
3 h (27). This approach allowed rule-out in 31% of
patients with a 30-day MACE rate of 0.4%. Compared
with all the aforementioned strategies, the investi-
gated ESC 0/1-h algorithm, as currently suggested by
the ESC with a Class I recommendation, tended to
result in a higher rule-out proportion (62%) and lower
30-day MACE rate (0.2%). However, patients’ popu-
lation differ between studies and a direct comparison
is still missing. Additionally, and in contrast to most
other algorithms, the ESC 0/1-h algorithm also offers a
clearly defined rule-in pathway.
The acceptable miss rate for MACE is still a
matter of debate and differs between health care
systems. However, on the basis of clinical surveys,
harm/benefit analyses, and most expert opinions,
PERSPECTIVES
COMPETENCY IN SYSTEMS-BASED PRACTICE: Routine
application of the ESC 0/1-h hs-cTnT algorithm facilitates rapid
triage of patients with acute chest discomfort and is associated
with low 30-day rates of major adverse cardiovascular events.
TRANSLATIONAL OUTLOOK: Additional clinical studies are
needed to compare the performance of the 0/1-h algorithm with
other rapid triage strategies for patients presenting with possible
acute myocardial infarction.
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493acceptable miss rates at 30 days should be <1% to 2%
in industrial countries (28,29), which is 5 to 10 times
higher than observed in this study.
The findings of the present study have enormous
clinical implications. Many hospitals worldwide are
currently switching from a conventional to a hs-cTn
assay, particularly after clearance of the first hs-
cTnT in the United States in Spring 2017. Besides,
many institutions that already use hs-cTn in clinical
routine still interpret it in the context of the ESC 0/3-h
algorithm despite the promising results of the ESC
0/1-h algorithm, as they first await confirmation by
real-world data.
As for any diagnostic algorithm, the following
concepts and caveats apply to the most appropriate
clinical use of the ESC 0/1-h algorithm: First, the ESC
0/1-h algorithm should only be applied in the appro-
priate clinical setting: hemodynamically stable pa-
tients presenting with symptoms suggestive of MI to
the ED after ST-segment elevation MI has been ruled
out by the ECG performed at presentation. As written
informed consent was required for this and nearly all
other previous studies on early triage algorithms,
very few patients in shock and/or respiratory failure
were enrolled. Second, although 30-day MACE rates
in the rule-out group of the ESC 0/1-h algorithm were
very low, and no NSTEMI was missed at index pre-
sentation, it should always be used in conjunction
with all other clinical information including detailed
assessment of chest pain characteristics, physical
examination, and the ECG. Additional measurements
of hs-cTnT at, for example, 3 h are advised whenever
the patient remains symptomatic or clinical judgment
still argues in favor of NSTEMI. These will help to
detect the rare, but existing phenomenon of delayed
release of hs-cTnT into the circulation, particularly in
early presenters (2). It will also help to detect rare, but
possible, errors in the handling of the clinical blood
samples. Third, not all patients triaged toward rule-
out of NSTEMI are appropriate candidates for early
discharge from the ED.
STUDY LIMITATIONS. First, we can only comment on
the performance of the ESC 0/1-h algorithm using hs-
cTnT. It is likely that also the real-world performance
of the ESC 0/1-h algorithm using hs-cTnI is similar to
that estimated in the large diagnostic studies.However, this hypothesis should be verified appro-
priately for each hs-cTnI assay in future studies.
Second, this study was conducted in ED patients with
symptoms suggestive of NSTEMI such as acute chest
discomfort and/or angina pectoris. Further studies
are required to quantify the utility of the ESC 0/1-h
algorithm in patients with either higher (e.g., in a
coronary care unit setting) or lower pre-test proba-
bility (e.g., in a general practitioner setting) for
NSTEMI. Third, we cannot comment on the utility of
the ESC 0/1-h algorithm in patients with terminal
kidney failure on chronic dialysis, because these pa-
tients were excluded from the initial studies deriving
and validating this algorithm (4,5).
CONCLUSIONS
The routine use of the ESC 0/1-h algorithm using hs-
cTnT in patients with acute chest discomfort is clin-
ically highly applicable and associated with very low
30-day MACE rates in the rule-out group and in out-
patients. The observed short ED stay length of only
2.5 h may be an important contribution to further
accelerate and improve patient management in the
often overcrowded EDs.
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